Bob-
You have to be careful with this doubling stuff (I know Walsh recommends it), but finasteride cuts PSA in half
on the average. Averages are a population statistic, not an individual statistic, so if an individual has better data, he should use that instead. Lacking pre-finasteride baseline data, it's best to just use the pattern of PSA as diagnostic. In fact, the pattern is
more diagnostic than if the man had never taken finasteride. What that means is that if PSA increases over time while on finasteride, it should be a trigger for further investigation.
If someone has pre-finasteride baseline PSA, one can see the actual effect of finasteride for him personally, so there is no need to estimate using a population statistic. If PSA doesn't go down at all after taking it, or if it goes down but rises again, those are triggers for further investigation.
Finasteride prevents low grade prostate cancer but not high grade prostate cancer. So if you have the high grade type, finasteride will shrink the prostate and make it easier to find.
So finasteride
improves the diagnostic performance of the PSA test and biopsies, prevents low grade PC, and may reduce it or render it undetectable for men on AS.
Post Edited (Tall Allen) : 2/15/2018 10:20:56 PM (GMT-7)